These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30321621)

  • 1. External stimulus responsive inorganic nanomaterials for cancer theranostics.
    M SM; Veeranarayanan S; Maekawa T; D SK
    Adv Drug Deliv Rev; 2019 Jan; 138():18-40. PubMed ID: 30321621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physically-triggered nanosystems based on two-dimensional materials for cancer theranostics.
    Ji DK; Ménard-Moyon C; Bianco A
    Adv Drug Deliv Rev; 2019 Jan; 138():211-232. PubMed ID: 30172925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart Organic-Inorganic Nanogels for Activatable Theranostics.
    Li F; Liang Z; Ling D
    Curr Med Chem; 2019; 26(8):1366-1376. PubMed ID: 28933302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic nanomaterials with rapid clearance for biomedical applications.
    Wang X; Zhong X; Li J; Liu Z; Cheng L
    Chem Soc Rev; 2021 Aug; 50(15):8669-8742. PubMed ID: 34156040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
    Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
    Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
    Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
    Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-responsive polymer-based nanosystems for cardiovascular disease theranostics.
    Liu Y; Li C; Yang X; Yang B; Fu Q
    Biomater Sci; 2024 Jul; 12(15):3805-3825. PubMed ID: 38967109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
    Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
    Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale theranostics for physical stimulus-responsive cancer therapies.
    Chen Q; Ke H; Dai Z; Liu Z
    Biomaterials; 2015 Dec; 73():214-30. PubMed ID: 26410788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications.
    Kim H; Beack S; Han S; Shin M; Lee T; Park Y; Kim KS; Yetisen AK; Yun SH; Kwon W; Hahn SK
    Adv Mater; 2018 Mar; 30(10):. PubMed ID: 29363198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of Theranostics in Rare Brain-Eating Amoebae Infections.
    Anwar A; Siddiqui R; Khan NA
    ACS Chem Neurosci; 2019 Jan; 10(1):6-12. PubMed ID: 30149693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice?
    Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W
    Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Carbon Nanomaterials for Cancer Phototherapy.
    Jiang BP; Zhou B; Lin Z; Liang H; Shen XC
    Chemistry; 2019 Mar; 25(16):3993-4004. PubMed ID: 30328167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of endogenous enzyme-responsive nanomaterials for theranostics.
    Mu J; Lin J; Huang P; Chen X
    Chem Soc Rev; 2018 Jul; 47(15):5554-5573. PubMed ID: 29856446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards tailored management of malignant brain tumors with nanotheranostics.
    Aparicio-Blanco J; Torres-Suárez AI
    Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing Hypoxia-Responsive Nanotheranostic Agents for Tumor Imaging and Therapy.
    Zhou H; Qin F; Chen C
    Adv Healthc Mater; 2021 Mar; 10(5):e2001277. PubMed ID: 32985141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.